55 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
policies relating to compensation and benefits of our officers and employees. Among other things, the Compensation Committee is responsible for:
reviewing … general policies relating to compensation and benefits of our employees.
The current members of our Compensation Committee are Kristina Burow, Matthew Fust
S-8
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Registration of securities for employees
4:34pm
or sold pursuant to the employee benefits plan described herein.
Represents shares of Common Stock that were automatically added to the shares
10-K
2023 FY
EX-10.23
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
Bonus in any year, and any Annual Bonus payment including the amount therein will be determined by the Company in its sole discretion.
(c)Benefits … duties, title, and responsibility and reporting level, work schedule, compensation and benefits, as well as the Company’s personnel policies
10-K
EX-97.1
2c58jk
7 Mar 24
Annual report
4:05pm
10-K
EX-10.22
2z5298e53x51ckploms
7 Mar 24
Annual report
4:05pm
10-K
a7wkboh9c9thcub3
7 Mar 24
Annual report
4:05pm
10-Q
lwp 71miss4bvzh
1 Nov 23
Quarterly report
4:05pm
S-8
EX-99.3
4pilx4s d9n6ic5s3nx
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.1
c02vi906w4idv2
19 Sep 23
Registration of securities for employees
9:57pm
8-K
EX-3.2
mvtgsj7k3mzd2mch
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
70lvk8u5
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
EX-10.13
wp6iy1mic
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
lrnajud
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-1.1
3wwyy1oebkk
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.7
mjsjnzdl
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.9
ahjdvnp0 md
25 Aug 23
IPO registration
5:03pm
S-1
tkh712
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.11
hzikwv85
25 Aug 23
IPO registration
5:03pm